These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies. Cavaletti G; Jakubowiak AJ Leuk Lymphoma; 2010 Jul; 51(7):1178-87. PubMed ID: 20497001 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial. Broyl A; Corthals SL; Jongen JL; van der Holt B; Kuiper R; de Knegt Y; van Duin M; el Jarari L; Bertsch U; Lokhorst HM; Durie BG; Goldschmidt H; Sonneveld P Lancet Oncol; 2010 Nov; 11(11):1057-65. PubMed ID: 20864405 [TBL] [Abstract][Full Text] [Related]
16. Assessment of bortezomib induced peripheral neuropathy in multiple myeloma by the reduced Total Neuropathy Score. Zaroulis CK; Chairopoulos K; Sachanas SP; Maltezas D; Tzenou T; Pessach I; Koulieris E; Koutra E; Kilindireas K; Pangalis GA; Kyrtsonis MC Leuk Lymphoma; 2014 Oct; 55(10):2277-83. PubMed ID: 24552516 [TBL] [Abstract][Full Text] [Related]
17. Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study. Tacchetti P; Terragna C; Galli M; Zamagni E; Petrucci MT; Pezzi A; Montefusco V; Martello M; Tosi P; Baldini L; Peccatori J; Ruggieri M; Pantani L; Lazzaro A; Elice F; Rocchi S; Gozzetti A; Cavaletti G; Palumbo A; Cavo M Am J Hematol; 2014 Dec; 89(12):1085-91. PubMed ID: 25159313 [TBL] [Abstract][Full Text] [Related]
18. Bortezomib-induced severe autonomic neuropathy. Stratogianni A; Tosch M; Schlemmer H; Weis J; Katona I; Isenmann S; Haensch CA Clin Auton Res; 2012 Aug; 22(4):199-202. PubMed ID: 22532274 [TBL] [Abstract][Full Text] [Related]
19. General aspects and mechanisms of peripheral neuropathy associated with bortezomib in patients with newly diagnosed multiple myeloma. Broyl A; Jongen JL; Sonneveld P Semin Hematol; 2012 Jul; 49(3):249-57. PubMed ID: 22726548 [TBL] [Abstract][Full Text] [Related]
20. Clinical assessment of bortezomib for multiple myeloma in comparison with thalidomide. Satoh M; Oguro R; Yamanaka C; Takada K; Matsuura Y; Akiba T; Aotsuka N; Tani Y; Wakita H J Pharm Pharm Sci; 2011; 14(1):78-89. PubMed ID: 21501555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]